Roche's petition against generic 'Risdiplam' dismissed by India's top court
Roche lost its bid at India's top court to halt Natco Pharma from selling a drastically cheaper generic of the SMA drug, Risdiplam, until a trial on a patent infringement suit is...To view the full article, register now.
Already a subscriber? Click here to view full article